Rosuvastatin Completed Phase 2 / 3 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT00555230Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis